|Biotech Due Diligence||
Recent highlights from around the web that have caught my eye as important reading material for the biotech enthusiast. Catch up on previous editions in the archives.
Happy holidays to those celebrating Easter and Passover this week. Enjoy the latest round-up of significant and thought-provoking scientific and medical journal articles. Find previous editions in the archives.
A Rough Guide to Spotting Bad Science
How to tell if a merger rumor will come true
Craig Silverman (Quartz)
Should Med School Leaders Serve on Pharma Boards?
John LaMattina (Forbes)
From Luddite to Guru: a Cynic’s Guide to Twitter for Biotech Professionals
TCP Innovations (Drug Baron blog)
Advice on making the most of the biotech community on Twitter, complete with a recommended list of followers.
These next two links are from brand-new blogs from valuable members of the Biotech Twitterverse: @bradloncar and @vikramkhanna_. Be sure to check out their websites and all of the other key resources highlighted on the BiotechDueDiligence Links page.
In this market, survival first is the name of the game
Brad Loncar (Loncar Blog)
Dismantling the biotech IPO bubble thesis
Vikram Khanna (BiotechVK)